Christoph KLEINSCHNITZ,Marc NOLTE,Anna-Leena SIRÉN,Christiane ALBERT-WEISSENBERGER,Sarah HOPP-KRAEMER
申请号：
US16666886
公开号：
US20200131248A1
申请日:
2019.10.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the use of a direct Factor XII (FXII) inhibitor in the treatment of a neurotraumatic disorder resulting from a traumatic injury of the brain (traumatic brain injury, TBI) or the spinal cord (spinal cord injury, SCI).
